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Preeclampsia is a serious disorder of human pregnancy. There is a hypothesis that Tumor 
Necrosis Factor and preeclampsia are associated. The aim of this systematic review and meta-




Articles related with genetic studies for TNFa -308 genotype in preeclampsia were 
chosen from Medline, EMBASE, Scopus, Web of Science and Google Scholar. The search was 
limited to the last decade, ie from 2006 onwards. The quality of the studies was evaluated using 
the STREGA statement. Meta-analysis was performed by using a random effect model. 
  
Results 
Finally, eleven studies were included for meta-analysis. Only one reported a statistically 
significant increased risk based on rs1800629. The pooled dataset was 1158 cases and 1336 
controls. Meta-analysis of these data showed no significant association between TNFa -308 
genotype and the risk of preeclampsia.  
 
Conclusion 
Meta-analysis of available articles documented no statistically significant association 
between tumor necrosis factor-a -308 polymorphism and preeclampsia. 
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Pregnancy can co-exist with a variety of complications and diseases. One serious 
complication is preeclampsia, formerly called “toxemia of pregnancy”. It is an hypertensive 
disorder specific to pregnancy. Preeclampsia may develop into the more severe condition 
eclampsia. It is dangerous for the expectant and the unborn and responsible for maternal and 
infant deaths. It affects 2 to 8% of all pregnancies worldwide [12].  
Principal features of preeclampsia are hypertension (a sustained diastolic blood pressure 
of 90 mm Hg or higher or a sustained systolic blood pressure of 140 mm Hg or higher) and 
proteinuria with or without edema. High blood pressure is dangerous because it may interfere 
with the placenta's ability to deliver oxygen and nutrition to the fetus. 
Any pregnant women can get preeclampsia but it is primarily a disease of the first 
pregnancy. Furthermore, women who are over age 35 or under 20 have a higher risk of 
developing preeclampsia. This disease is more common to women with low standards of living. 
Other risk factors are multiple pregnancy, diabetes, high blood pressure, kidney disease, 
hydramnios, trophoblastic disease, gestation with down syndrome and smoking. Moreover, 
women with preexisting hypertension have twice the risk of getting preeclampsia [14]. 
The etiology of preeclampsia is still unclear. However, it is sure that the daughters of 
women who had preeclampsia during pregnancy have more risk of preeclampsia themselves 
compared with other women [1]. 
Many genetic studies were conducted to determine the pathophysiology of preeclampsia. 
The Tumor Necrosis Factor gene is a putative genetic risk factor for this disease.  
The tumor necrosis factor (TNF) superfamily refers to a group of cytokines that can 
cause cell death. Cell death is the programmed cell death, which is a normal process by which 
the body controls the number of cells. TNFα or TNF alpha, is the best known member of this 
class. TNF alpha can be produced by many cell types such as CD4+ lymphocytes, NK cells, 
neutrophils, mast cells, eosinophils, neurons or by activated macrophages, and is a cell signaling 
protein involved in systemic inflammation and is one of the cytokines that make up the acute 
phase reaction. 
Its role is in the regulation of immune cells. TNF, being an endogenous pyrogen, is able 
to induce fever, apoptotic cell death, cachexia, inflammation and to inhibit tumorigenesis and 
viral replication and responds to sepsis via IL1 &IL6 producing cells. Dysregulation of TNF 
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production has been implicated in a variety of human diseases including Alzheimer's disease, 
cancer, major depression, Psoriasis and inflammatory bowel disease (IBD). While st ill 
controversial, studies of depression and IBD are currently being linked to TNF levels. 
Recombinant TNF is used as an immunostimulant under the INN tasonermin. TNF can be 
produced ectopically in the setting of malignancy and parallels parathyroid hormone both in 
causing secondary hypercalcemia and in the cancers with which excessive production is 
associated [11]. 
As mentioned above, one more human disease that TNF is implicated is preeclampsia. 
One studied variant in the TNF gene is the guanine to adenine transition at position -308 
nucleotides. The findings for the association of the TNF polymorphism with preeclampsia are 
conflicting. A systematic review and meta-analysis of data from genetic studies may give more 
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A systematic literature search was conducted in the MEDLINE (PubMed), Embase, 
Scopus, Web of Science and Google Scholar databases using a combination of the following 
keywords: preeclampsia, TNF, TNF- a Tumor necrosis factor, rs1800629 and TNF- 308. The 
search was limited between January 2006 and August 2016. The language of publications was 
only in English. Selection of these databases allowed us to search articles from US and European 
journals. Moreover, the reference section of these articles was reviewed manually to find 
additional published studies. 
 
Study Eligibility Criteria 
Studies which assessed the association of the TNF (-308G/A) polymorphism with 
preeclampsia were eligible for inclusion if: 
1. Preeclampsia was defined as the onset of hypertension with or without proteinuria. 
Hypertension was defined as systolic blood pressure ≥140 mmHg and/or ≥90 mmHg 
diastolic pressure blood. Proteinuria was defined as the excretion of urine protein ≥300 
mg in a 24-hour. 
2. The sample was women. 
3. Genetic data were presented. 
4. Their full texts were available. 
5. These were published in the English language. 
Studies were excluded if:  
1. These were not related to TNF-308G/A (rs1800629) in preeclampsia. 
2. These were review articles, abstracts, posters of a conference. 
3. Data were unclear. 
 
Data Extraction 
From each paper information regarding was extracted the first author’s name, the sample 
size, the study design, the study location and outcomes (Table 2). 
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We did not exclude any low quality papers because we wanted a complete understanding 
of all relative studies. 
 
Quality Assessment 
The quality of selected case-control studies assessed using the Strengthening the 
Reporting of Genetic Association Studies (STREGA) statement [9]. STREGA statement consists 
of 22 items. Specifically, the 22-item quality criteria were (Table 1): (1) indication of study 
design and provision of an informative and balanced summary, (2) background rationale, (3) 
clear statement of objectives and hypothesis (4) study design, (5) setting (location and relevant 
dates), (6) eligibility criteria for study participants, (7) definition of all variables, (8) sources of 
data/ details of methods of measurement, laboratory methods (9) efforts to address potential 
sources of bias, (10) study size, (11) how quantitative variables were handled in the analyses, 
(12) description of statistical methods, sensitivity analyses, statement of Hardy-Weinberg 
equilibrium,  (13) report of participants, (14) sufficient descriptive data, (15) report numbers and 
outcomes for each genotype category, (16) report main results, (17) other analyses, (18) 
summarize key results with reference to study, (19) report of limitations, (20) an overall 




Genotype data were analyzed by merging homozygous for wild type allele versus mutant 
type allele-carriers (GG vs GA+AA). Review Manager 5.3.5 (Cochrane Collaboration, Oxford, 
United Kingdom) used for data analysis. The heterogeneity tested with Q statistic and it was 
used Random effect model. Also the Mantel- Haenszel method was adopted with pooled OR. 
The results are presented in a standard plot and 95% confidence interval. 
To check for the existence of publication bias it was used a funnel plot. 
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Characteristics of Included Studies 
Ten articles were found reporting eleven case-control studies [2-8, 10, 12, 13]. A total of 
1158 cases with preeclampsia and 1336 controls participated in the study. The studies provided 
sufficient data and had good methodological quality, according to STREGA statement [9] (Table 
1). Almost all of them were performed Hardy – Weinberg equilibrium test.  
Most of studies were based in Slovakia, Turkey, Austria and Hungary. The participants 
were of Caucasian ethnic ancestry [6-8, 10, 13]. Three studies were in Brazil and the participants 
were Caucasian [3] in one and Mulatto/Black in the other two [3, 4]. In a study from Mexico, 
participants were Maya – Mestizo ethnicity [2], whereas in studies from China [12] and Iran [5], 
participants were Chinese and Iranian, respectively. 
Cases were women who fulfilled the criteria of preeclampsia. They had systolic blood 
pressure ≥140mm Hg and/or diastolic blood pressure ≥90mm Hg with proteinuria at least 300mg 
in a 24-hour urine specimen after 20 weeks’ gestation. Controls were women with no history of 
preeclampsia, natural blood pressure and their gestation was without complications.  
The basic characteristics of each study are presented in Table 2.  
 
Quality Assessment 
The quality of the studies was evaluated by applying the 22-item checklist of STREGA 
statement. All the included studies have an enlightening abstract which indicate the study design. 
Furthermore, their introductions declare the scientific background and the objectives of the 
genetic studies.  
In the section of methods study design, study size, location, relevant dates and data 
collection (setting) are described. All included studies describe clearly the eligibility criteria for 
all participants, sources of data, laboratory methods, quantitative variables like age and statistical 
methods. Quantitative variables are used as criteria of inclusion in the studies. None of the 
studies did not describe potential sources of bias clearly and sensitivity analyses. Seven studies 
mention that the Hardy-Weinberg equilibrium test was performed [2-4, 6, 10, 12, 13]. In the part 
of methods the definition of potential confounders, effect modifiers and genetic exposures are 
unclear. 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 13:06:51 EET - 137.108.70.7
7 
 
Results of all studies contain data for participants and their characteristics like age, body 
mass index, systolic and diastolic blood pressure or other environmental factors like smoking. 
They mention numbers in each genotype category. Main results and other analyses are reported. 
Some of them did meta-analyses [3, 6, 7], one subgroup analysis [13] and the rest examined 
numerous genetic variants.  
In the end, in the part of discussion all articles summarize the basic results and give an 
overall interpretation of results.  Only half of them discuss limitations for external validity and 
almost all give the source of funding.  
Quality assessment of each study is presented in Table 1. 
 
Genotype Association 
A meta-analysis for investigating the association between preeclampsia and the TNF 
(wt=G and mt=A) gene polymorphism produced significant heterogeneity (p=0.007<0.05). 
All the included studies did not find a statistical significant association between TNF -
308G except for one [5]. 
No statistically significant association was found between TNF (rs1800629) and 
preeclampsia (pooled OR=1.01, 95% CI (0.69, 1.49), p=0.96) (Figure 1).  
 
Publication Bias 
An asymmetry in funnel plot indicates the existence of publication bias (Figure 2). 
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The purpose of this meta-analysis was to evaluate the association of TNF -308G/A gene 
polymorphism with a disease of pregnant women: preeclampsia. Eleven case-control studies 
were included and the search for relative articles was limited from 2006 until today. The result 
shows no association between the variant TNF (rs1800629) and the risk of developing 
preeclampsia.  
Although data were not from different study designs, heterogeneity was found with I
2
 = 
59%. Possible reasons are the definition of phenotype, genotyping misclassification, selection of 
sample, confounded by ethnic origin and multiple testing. 
The development of preeclampsia may be associated with genetic factors but should take 
into account other environmental factors. Environmental factors like fumes or environmental 
toxins and diet, before and during pregnancy, might play a role in the development of 
preeclampsia. 
Because of these findings we cannot eliminate the possibility that TNF plays a role in the 
developing of preeclampsia. More genetic studies in larger populations, taking into consideration 
genetic, environmental and alimentary factors, will give an overall image and more precisely 
results, minimizing possible bias.  
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Table 1 - Quality Assessment Studies of TNF (rs1800629) in preeclampsia 
Study Title and 
Abstract 

















































































































































































Daher et al, 2006 
+ + + + + + + unclear + + - + + + - + 
Pazarbasi et al, 
2007 
+ + + + + + + unclear + + - + + + - - 
Canto-Centina et 
al, 2007 
+ + + + + + + unclear + + - + + + - + 
Molvarec et al, 
2008 
+ + + + + + + unclear + + - + + + - + 
Stonek et al, 2008 + + + + + + + unclear + + - + + + - - 
Mirahmadian et 
al, 2008 
+ + + + + + + unclear + + - + + + - - 
De Lima et al, 
2009 
+ + + + + + + unclear + + - + + + - + 
Vural et al, 2010 + + + + + + + unclear + + - + + + - + 
Zubor et al 2014 + + + + + + + unclear + + - + + + - + 
Zhou et al, 2016 + + + + + + + unclear + + - + + + - + 
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Daher et al, 2006 + - + + + + - + + + 
Pazarbasi et al, 2007 + + + + + + + + + - 
Canto-Centina et al, 2007 + + + + + + - + + + 
Molvarec et al, 2008 + + + + + + + + - + 
Stonek et al, 2008 + - + + - + - + - - 
Mirahmadian et al, 2008 + + + + - + - + - + 
De Lima et al, 2009 + + + + - + + + + + 
Vural et al, 2010 + + + + - + - + + + 
Zubor et al 2014 - + + + + + - + - + 
Zhou et al, 2016 + + + + + + + + + + 
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Table 2 - Characteristics of included studies 
Reference Setting Ethnicity Case definition Controls 
Daher et al, 
2006 (a) 
Brazil Caucasian SBP≥140 and/or DBP≥90 on two 
occasions with persistent urine protein ≥ 
300 mg/24 h, n = 56 
Normotensive 
primigravidae 
women, n = 92) 
Daher et al, 
2006 (b) 
Brazil Mulatto & 
Black 
SBP≥140 and/or DBP≥90 on two 
occasions with persistent urine protein ≥ 
300 mg/24 h, n = 94 
Normotensive 
primigravidae 
women, n = 97 
Pazarbasi et 
al, 2007 
Turkey Caucasian SBP≥140 and/or DBP≥90 and new onset 
proteinuria>300 mg/24 h, n = 152 
Normotensive 
primigravidae 
women, n = 80 
Canto-




SBP≥140 and/or DBP≥90 on two 
occasions at least 
24 h apart with persistent urine protein ≥ 
300 mg/24 h, n = 105 
Normotensive 
pregnant 
women, n = 200 
Molvarec et 
al, 2008 
Hungary Caucasian SBP ≥ 140 & DBP≥90 with proteinuria ≥ 
300 mg/24 h, n = 209 (69 
cases had HELLP syndrome) 
Normotensive 
pregnant 
women, n = 144 
Stonek et al, 
2008 
Austria Caucasian SBP ≥ 160 or DBP ≥ 110 on two 
occasions >4 h apart with new onset 
proteinuria ≥ 300 mg/24 h, n = 107 
Normotensive 
pregnant 
women, n = 107 
Mirahmadian 
et al, 2008 
Iran Iranian SBP≥140 mmHg or DBP≥90 mmHg on 
two occasions 6 hr with proteinuria ≥ 
300 mg/24 h, n = 160 
Normotensive 
pregnant 
women, n = 100 




SBP≥140 and/or DBP≥90 and new onset 
proteinuria>300 mg/24 h, n = 88 
Normotensive 
pregnant 
women with a 
history of at 
least one 
previous normal 
pregnancy, n = 
97 
Vural et al 
2010 
Turkey Caucasian SBP ≥ 140 & DBP ≥ 90 on two 
occasions 6 h with new onset proteinuria 
≥ 300 mg/24 h, n = 101 
Non pregnant 
healthy women, 
n = 95 
Zubor et al 
2014 
Slovakia Caucasian SBP ≥ 140 & DBP ≥ 90 on two 
occasions  6 h with new onset proteinuria 
≥ 300 mg/24 h, n = 38 
Normotensive 
primigravid 
women, n = 38 
Zhou et al, 
2016 
China Chinese SBP ≥ 140 & DBP ≥ 90 and/or 
proteinuria ≥ 300 mg/24 h or a positive 
urine dipstick test at 2+without urinary 
infection, n = 117 
Normotensive 
primigravidae 
women, n = 286 
SBP: systolic blood pressure; DBP: diastolic blood pressure; HELLP: haemolysis, elevated liver 
enzymes, low platelets                                                                                                                                                                                                                                                           
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Figure 2 - Funnel plot 
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